{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:06:28Z","timestamp":1780344388615,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.atherosclerosis.2009.05.037","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T04:22:59Z","timestamp":1245385379000},"page":"608-613","source":"Crossref","is-referenced-by-count":30,"title":["The formation of monocyte\u2013platelet aggregates is independent of on-treatment residual agonists\u2019-inducible platelet reactivity"],"prefix":"10.1016","volume":"207","author":[{"given":"Thomas","family":"Gremmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Seidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana-Aura","family":"Giurgea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Koppensteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/hc3801.095588","article-title":"Circulating monocyte\u2013platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction","volume":"104","author":"Michelson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(01)01485-1","article-title":"Circulating monocyte\u2013platelet aggregates are an early marker of acute myocardial infarction","volume":"38","author":"Furman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/ATVBAHA.107.161471","article-title":"Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet\u2013leukocyte aggregates","volume":"28","author":"Brambilla","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00395-007-0667-y","article-title":"Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation","volume":"102","author":"Kalsch","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0609.2006.00808.x","article-title":"C-reactive protein promotes monocyte\u2013platelet aggregation: an additional link to the inflammatory-thrombotic intricacy","volume":"78","author":"Danenberg","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib6","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH08-05-0313","article-title":"Greater reduction of platelet activation markers and platelet\u2013monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease","volume":"100","author":"Braun","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1160\/TH07-01-0010","article-title":"The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: influence of other blood cells, calcium, and aspirin","volume":"98","author":"Frelinger","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1538-7836.2007.02838.x","article-title":"The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities","volume":"6","author":"Frelinger","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/hrt.2005.083006","article-title":"Clopidogrel reduces platelet\u2013leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus","volume":"92","author":"Harding","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0037-1613242","article-title":"Inhibition of ADP-induced P-selectin expression and platelet\u2013leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin","volume":"88","author":"Storey","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.0000225288.74170.dc","article-title":"Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects","volume":"26","author":"Heitzer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.08.002","article-title":"Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet\u2013leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers","volume":"78","author":"Graff","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet\u2013leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib16","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","article-title":"Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events","volume":"5","author":"Bonello","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/01.CIR.0000158665.27783.0C","article-title":"Simvastatin blunts endotoxin-induced tissue factor in vivo","volume":"111","author":"Steiner","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3324\/haematol.10999","article-title":"Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count","volume":"92","author":"Cattaneo","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1538-7836.2008.02891.x","article-title":"Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary","volume":"6","author":"Linnemann","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2006.10.021","article-title":"Aspirin resistance and adverse clinical events in patients with coronary artery disease","volume":"120","author":"Chen","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2008.07.055","article-title":"Calcium-channel blockers reduce the antiplatelet effect of clopidogrel","volume":"52","author":"Siller-Matula","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1160\/TH08-09-0577","article-title":"Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation","volume":"101","author":"Gremmel","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH07-04-0296","article-title":"ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome","volume":"98","author":"Frere","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib28","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib29","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/j.1538-7836.2007.02656.x","article-title":"Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients","volume":"5","author":"Paniccia","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI117442","article-title":"A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2","volume":"94","author":"Diacovo","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib32","doi-asserted-by":"crossref","first-page":"45375","DOI":"10.1074\/jbc.M304344200","article-title":"High molecular weight kininogen regulates platelet\u2013leukocyte interactions by bridging Mac-1 and glycoprotein Ib","volume":"278","author":"Chavakis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1084\/jem.192.2.193","article-title":"Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b\/CD18)","volume":"192","author":"Simon","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.037_bib34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1055\/s-0037-1616128","article-title":"Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation","volume":"86","author":"McEver","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009004560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009004560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T20:12:58Z","timestamp":1558383178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009004560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0021915009004560"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.037","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}